DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Ajanta Pharma Limited (AJANTPHARM) share price today?

Ajanta Pharma Limited (AJANTPHARM) is trading at ₹3,320.2 on the NSE, down 1.17% on the day. Source: DocStoX.

What is the PE ratio of Ajanta Pharma Limited?

Ajanta Pharma Limited has a price-to-earnings (PE) ratio of 39.3 in the Healthcare sector.

What is the market capitalisation of Ajanta Pharma Limited?

Ajanta Pharma Limited has a market capitalisation of approximately ₹41,525 crore.

Is Ajanta Pharma Limited a profitable company?

Ajanta Pharma Limited generates a return on equity of 23.3% with a net profit margin of 19.4%. That is a strong return on shareholder capital.

What is the 52-week high and low of AJANTPHARM?

Ajanta Pharma Limited (AJANTPHARM) has traded between ₹2,382 and ₹3,796 over the past 52 weeks, against a current price of ₹3,320.2.

Does Ajanta Pharma Limited pay a dividend?

Yes. Ajanta Pharma Limited currently offers a dividend yield of 0.91%. Dividend payments depend on the board's declaration each year.

Ajanta Pharma Limited

₹3,320.20▼ -39.20 (-1.17%)

AJANTPHARM·NSE·Healthcare

Market Cap

41524.51 Cr

PE Ratio

39.28

Volume

38,355

Day High - Low

3381.00 - 3308.30

52W High-Low

3796.00 - 2382.00

₹3,320.20▼ -39.20 (-1.17%)

Market Cap41524.51 Cr

PE Ratio39.28

Volume38,355

Day High - Low3381.00 - 3308.30

52W High-Low3796.00 - 2382.00

Ajanta Pharma Limited (AJANTPHARM): company summary

The company's business is improving, with annual revenue rising 17.3% and annual net profit rising 14.8%.

Ajanta Pharma Limited (AJANTPHARM) is a mid-cap Healthcare company valued at ₹41,525 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Ajanta Pharma Limited last traded at ₹3,320.2, modestly down 1.17% on the day.
Recent developments: On 2026-07-30, Ajanta Pharma reported its Q1 results, showing a 31% rise in PAT to ₹334 crore, driven by strong sales in India and the US.
Financial performance: The company's business is improving, with annual revenue rising 17.3% and annual net profit rising 14.8%. The latest quarter saw revenue rise 24.8% and net profit rise 31.1% compared to the same quarter a year earlier. The net profit margin narrowed slightly to 19.4% from 19.8% in the prior year, while return on equity remained at 23.3%.
Valuation multiples: The stock trades at 39.3 times earnings, a premium to the Healthcare median of 32.0, 9.71 times book value. It yields 0.9%.
Things to watch: The stock is 10.2% below its 52-week high. Promoter holding fell by 2.77 percentage points in the quarter. Promoter shares pledged account for 22.53% of promoter holding.
Where it stands: The company's latest quarter net profit rose 31.1% to ₹334 crore, while the stock is 10.2% below its 52-week high. Promoter holding fell by 2.77 percentage points in the quarter.

Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

6.3/10

Fair

Fair Value

ROE

23.33%

Strong

P/E

39.28x

Expensive

Debt / Equity

0.06

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

NIFTY 500NIFTY MIDCAP 150NIFTY PHARMA

Day₹3308

₹3381

52W₹2382

₹3796

DocStoX take

Supported by quality (8.6) and risk (8.6), but held back by valuation (0.9). Quality looks strong at 8.6, but that is offset by valuation at 0.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

6.3

/10

Fair

Quality

Excellent

ROE 23.3%

Valuation

Expensive

P/E 39.3×

Growth

Steady

Revenue +13.5% 5Y CAGR

Risk

Low risk

D/E 0.06

Momentum

Firm

66% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹3,320

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹41,525 Cr

52W High / Low

₹3796 / ₹2382

Dividend Yield

0.91%

Promoter Holding

63.47%

EPS (TTM)

₹84.53

Book Value

₹361.16

Key highlights

Low leverage — D/E 0.06
Capital works hard — ROCE 29%
Profitable in all of the last 5 years
21% of promoter holding is pledged
Valuation is weak (0.9/10)

4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Ajanta Pharma Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Ajanta Pharma Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Ajanta Pharma Limited with peers

Ajanta Pharma Limited vs Sun Pharmaceutical Industries Limited Ajanta Pharma Limited vs Divi's Laboratories Limited Ajanta Pharma Limited vs Torrent Pharmaceuticals Limited Ajanta Pharma Limited vs Apollo Hospitals Enterprise Limited Ajanta Pharma Limited vs Zydus Lifesciences Limited Ajanta Pharma Limited vs Laurus Labs Limited

Related tools & concepts

Value Ajanta Pharma Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

AJANTPHARM newsLatest coverage & filings Open screenerFilter the whole market